BillionToOne, Inc. Class A Common Stock (BLLN) - Total Assets

Latest as of March 2026: $700.73 Million USD

Based on the latest financial reports, BillionToOne, Inc. Class A Common Stock (BLLN) holds total assets worth $700.73 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BLLN total equity for net asset value and shareholders' equity analysis.

BillionToOne, Inc. Class A Common Stock - Total Assets Trend (2023–2025)

This chart illustrates how BillionToOne, Inc. Class A Common Stock's total assets have evolved over time, based on quarterly financial data.

BillionToOne, Inc. Class A Common Stock - Asset Composition Analysis

Current Asset Composition (December 2025)

BillionToOne, Inc. Class A Common Stock's total assets of $700.73 Million consist of 88.6% current assets and 11.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 78.4%
Accounts Receivable $41.62 Million 6.6%
Inventory $17.55 Million 2.8%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $587.00K 0.1%
Goodwill $0.00 0.0%

Asset Composition Trend (2023–2025)

This chart illustrates how BillionToOne, Inc. Class A Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BillionToOne, Inc. Class A Common Stock stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: BillionToOne, Inc. Class A Common Stock's current assets represent 88.6% of total assets in 2025, an increase from 60.3% in 2023.
  • Cash Position: Cash and equivalents constituted 78.4% of total assets in 2025, up from 50.8% in 2023.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
  • Asset Diversification: The largest asset category is accounts receivable at 6.6% of total assets.

BillionToOne, Inc. Class A Common Stock Competitors by Total Assets

Key competitors of BillionToOne, Inc. Class A Common Stock based on total assets are shown below.

Company Country Total Assets
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
India Rs31.46 Billion
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Check-Cap Ltd.
NASDAQ:MBAI
USA $7.49 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million

BillionToOne, Inc. Class A Common Stock - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 10.92 5.92 8.03
Quick Ratio 10.58 5.58 7.72
Cash Ratio 0.00 0.00 0.00
Working Capital $566.98 Million $196.28 Million $199.43 Million

BillionToOne, Inc. Class A Common Stock - Advanced Valuation Insights

This section examines the relationship between BillionToOne, Inc. Class A Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 8.49
Latest Market Cap to Assets Ratio 5.53
Asset Growth Rate (YoY) 109.4%
Total Assets $632.65 Million
Market Capitalization $3.50 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values BillionToOne, Inc. Class A Common Stock's assets at a significant premium (5.53x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: BillionToOne, Inc. Class A Common Stock's assets grew by 109.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for BillionToOne, Inc. Class A Common Stock (2023–2025)

The table below shows the annual total assets of BillionToOne, Inc. Class A Common Stock from 2023 to 2025.

Year Total Assets Change
2025-12-31 $632.65 Million +109.45%
2024-12-31 $302.06 Million +57.59%
2023-12-31 $191.68 Million --

About BillionToOne, Inc. Class A Common Stock

NASDAQ:BLLN USA Diagnostics & Research
Market Cap
$3.50 Billion
Market Cap Rank
#4581 Global
#1505 in USA
Share Price
$84.48
Change (1 day)
-1.68%
52-Week Range
$64.03 - $130.18
All Time High
$130.18
About

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, an… Read more